Frontier Pharma: Orphan and Rare Dermatological Diseases - First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa

  • RnM2474174
  • |
  • 11 October, 2018
  • |
  • 86 pages
  • |
  • GBI Research
  • |
  • Pharmaceuticals & Healthcare
1-user PDF :    $6,995.00
1-5 User PDF :   $13,990.00
Enterprise PDF :    $20,985.00

Make an enquiry before buying this Report



Purchase this Report

$6,995.00
$13,990.00
$20,985.00
5,605.41
11,210.82
16,816.22
6,236.93
12,473.86
18,710.79
754,480.70
1,508,961.40
2,263,442.10
481,930.32
963,860.64
1,445,790.95
Credit card Logo